Clinical trial data key to personalization of treatment decisions
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
By
Machine learning is a powerful form of artificial intelligence that is affecting every industry. Here’s what you need to know about its potential and limitations and how it’s being used.
We push the boundaries of finance to solve complex problems and fuel progress in the world through the MIT finance ecosystem – a unique global network of people, programs, research, and partnerships.
By
In a new book about the history of Kendall Square from the MIT Press, author Robert Buderi chronicles the area's biggest successes in innovation.
By
Matt Beane, SM ’14, PhD ’17, argues those using artificial intelligence will become incrementally de-skilled unless they are consciously upskilling at the same time.
MassRobotics, a nonprofit founded by several MIT alumni, is advancing an industry that will play an increasingly important role in our lives.
Ahead of the presidential inauguration, MIT Sloan's Professor Andrew Lo and other panelists described advances in their research and how these discoveries are being deployed to benefit the public.
MIT spinout Verta, founded by Manasi Vartak, SM ’14, PhD ’18, offers tools to help companies introduce, monitor, and manage machine-learning models safely and at scale.
The technology of MIT alumni-founded Hosta AI creates detailed property assessments from photos.